{"database": "openregs", "table": "documents", "rows": [["FDA-2015-N-3469-0001", "FDA", "FDA-2015-N-3469", "Bulk Drug Substances That Can Be Used To Compound Drug Products in\nAccordance With Section 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket", "Notice", "Notice of Availability", "2015-10-27T04:00:00Z", 2015, 10, "2015-10-27T04:00:00Z", "2050-02-22T04:59:59Z", "2026-01-24T10:08:13Z", "2015-27270", 1, 0, "0900006481cf17b1"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-N-3469-0001"], "units": {}, "query_ms": 169.76726707071066, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}